Förster Resonance Energy Transfer Based Biosensor for Targeting the hNTH1–YB1 Interface as a Potential Anticancer Drug Target

Müge Senarisoy, Caroline Barette, Françoise Lacroix, Salvatore De Bonis, Meike Stelter, Fabienne Hans, Jean-Philippe Kleman, Marie‐Odile Fauvarque, Joanna Timmins

ACS Chemical Biology · 2020 · 13 citations · 39 references

DOIFull text

Open access

Concepts

Abstract

values in the low micromolar range. Interestingly, two of these compounds bind to YB1 and sensitize drug-resistant breast tumor cells to the chemotherapeutic agent, cisplatin. Taken together, these findings demonstrate that the hNTH1-YB1 interface is a druggable target for the development of new therapeutic strategies for the treatment of drug-resistant tumors. Moreover, beyond this study, the simple design of our biosensor defines an innovative and efficient strategy for the screening of inhibitors of therapeutically relevant protein-protein interfaces.

References

39